BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 22612875)

  • 1. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
    Mummidi V; Jayanthi V
    Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin.
    Chowdary KP; Srinivas SV
    AAPS PharmSciTech; 2006 Sep; 7(3):79. PubMed ID: 17025259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl β-cyclodextrin.
    Chowdary KP; Srinivas SV
    AAPS PharmSciTech; 2006 Sep; 7(3):E184-E189. PubMed ID: 28290014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
    Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
    Jablan J; Szalontai G; Jug M
    J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.
    Asbahr AC; Franco L; Barison A; Silva CW; Ferraz HG; Rodrigues LN
    Bioorg Med Chem; 2009 Apr; 17(7):2718-23. PubMed ID: 19282187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of water soluble polymers on hydroxypropyl-beta-cyclodextrin complexation of rofecoxib.
    Singh I; Aboul-Enein HY
    Pharmazie; 2007 Apr; 62(4):284-6. PubMed ID: 17484284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Hydrophilic Polymers on Complexation Efficiency of Cyclodextrins in Enhancing Solubility and Release of Diflunisal.
    Bashir M; Syed HK; Asghar S; Irfan M; Almalki WH; Menshawi SA; Khan IU; Shah PA; Khalid I; Ahmad J; Gohar UF; Peh KK; Iqbal MS
    Polymers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel application of tertiary butyl alcohol in the preparation of hydrophobic drug-HPbetaCD complex.
    Wang Z; Deng Y; Zhang X
    J Pharm Pharmacol; 2006 Mar; 58(3):409-14. PubMed ID: 16536910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M; Kosalec I; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin.
    Medarević D; Kachrimanis K; Djurić Z; Ibrić S
    Eur J Pharm Sci; 2015 Oct; 78():273-85. PubMed ID: 26255049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.